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Objective. To describe the clinicopathologic, immunohistochemical, and scanning electron microscopic features of 19 cases of
calcifying epithelial odontogenic tumor (CEOT) in comparison to 4 cases of dental follicles containing CEOT-like areas (DF-CEOT).
Study Design. A collaborative Latin American retrospective study.
Results. CEOT and DF-CEOT showed a slight predilection for females, mostly affecting the posterior mandible. CEOTs were
classified as epithelium-rich (8 cases), amyloid-rich (4), and calcification-rich (3), and 4 cases showed similar proportion of the
3 components. DF-CEOTs contained odontogenic epithelium, amyloid, calcification, and clear cells. Epithelial cells were
positive for cytokeratins CK5 and CK19, E-cadherin, and syndecan 1 (CD138), and focally for amyloid A. In CEOT, amyloid
was positive for CD138 and amyloid A, and calcification for CK5, CD138, and amyloid A. In DF-CEOT, calcification was
positive for amyloid A. CEOT showed higher Ki-67 protein and minichromosome maintenance complex component 2
(MCM-2) labeling indices than did DF-CEOT. In scanning electron microscopy, CEOT calcified material resembled bone in the
3 cases classified as calcification-rich.
Conclusions. CEOT and DF-CEOT showed histomorphologic and immunohistochemical similarities, and the histogenetic
significance of these features should be further studied. (Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:759-768)Calcifying epithelial odontogenic tumor (CEOT) is
a rare entity, comprising about 1% of all odontogenic
tumors (OTs).1-3 OTs may develop from proliferative
odontogenic epithelial remnants, including those
present in dental follicles (DFs),4 and CEOT-like areas
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http://dx.doi.org/10.1016/j.oooo.2013.08.023Thus, the aim of this multicenter collaborative study is
to describe the clinicopathologic features from a series
of 19 CEOTs, including immunohistochemical and
scanning electron microscopic features, and to compare
these ﬁndings with those found in 4 cases of DF
showing CEOT-like areas (DF-CEOT).MATERIAL AND METHODS
Nineteen cases of CEOT and 4 cases of DF-CEOT were
retrieved from the ﬁles of 5 Latin American oral
pathology diagnostic services for this retrospective
cross-sectional study (State University of Rio de
Janeiro, Rio de Janeiro, Brazil; Federal University of
Rio de Janeiro, Rio de Janeiro, Brazil; State University
of Campinas, Piracicaba, Brazil; Universidad Autón-
oma Metropolitana Xochimilco, Mexico City, Mexico;
Centro Clínico de Cabeza y Cuello, Guatemala City,Statement of Clinical Relevance
CEOT is a rare odontogenic tumor, and dental
follicles may contain CEOT-like areas (DF-CEOT),
but this true signiﬁcance is unknown. Herein, the
authors describe the clinicopathologic features of
these entities, highlighting their histomorphologic
and immunohistochemical similarities.
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Table I. Summarized data about CEOT from clinicopathologic case series published in the English-language
literature
Authors, year Country/region N
Data from CEOT cases
Intraosseous/
extraosseous
Gender
(M/F)
Mean age
(range) (y) Site Radiologic image*
Unerupted
tooth*
Present study Latin America 19 17/2y 8/10 37.2 (13-65) 12 Mand/4 Max 6 RL/10 MIX 10
Patiño et al., 2005 Spain 4 3/1 2/2 41.3 (27-67) 3 Mand/1 Max 1 RL/2 MIX 0
Ng et al., 1996 Malaysia 13 12/1 5/8 31.8 (19-61) 3 Mand/10 Max NS 6
Ai-Ru et al., 1982 China 9 7/2 2/7 34.2 (20-64) 8 Mand/1 Max NS NS
Krolls & Pindborg, 1974 United States 23 22/1 13/10 38.6 (8-72) 18 Mand/5 Max NS 8
Abrams & Howell, 1967 United States 4 3/1 2/2 38.3 (16-54) 4 Mand/0 Max 0 RL/3 MX 1
Total - 53 47/6 24/29 36.8 (8-72) 36 Mand/17 Max 7 RL/15 MIX 15
CEOT, calcifying epithelial odontogenic tumor; NS, not speciﬁed;M, male; F, female;Mand, mandible;Max, maxilla; RL, radiolucent;MIX, mixed.
*Data about radiologic image and association with unerupted tooth included only intraosseous cases and available information.
yThese cases occurred bilaterally in the same patient and were previously reported.9
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760 Azevedo et al. December 2013Guatemala). Demographic, clinical, and radiologic data
were obtained from the laboratories’ records. All cases
were analyzed under light microscopy using 5-mm
sections on histologic slides stained with hematoxylin-
eosin (HE), Congo red (CR), and periodic acideSchiff
(PAS). CR-stained sections were also analyzed under
polarized light microscopy, and 3 CEOT cases were
additionally submitted to scanning electron microscopy
(SEM) analysis using 5-mm gold-coated specimens.
Sections (3 mm thick, on silane-coated histologic
slides) from 17 CEOTs and 3 DF-CEOTs were submitted
to immunohistochemical analysis with antibodies dir-
ected to cytokeratin 5 (CK5, clone, XM 26; Novocastra
Laboratories, United Kingdom; 1:400), cytokeratin 19
(CK19, clone RCK 108; Dako A/S, Denmark; 1:200),
syndecan 1 (CD138, clone My 15; Dako A/S; 1:100), E-
cadherin (clone NCH-384; Dako A/S; 1:200), amyloid A
(AA, clone MC1; Dako A/S; 1:400), protein Ki-67 (clone
MIB-1; Dako A/S; 1:100), and minichromosome main-
tenance complex component 2 (MCM-2) (clone NCL-
MCM2; Novocastra Laboratories; 1:30) by using the
streptavidin biotin method (Strept ABComplex/HRP
Duet, Mouse/Rabbit; Dako A/S) and visualization with
diaminobenzidine tetrahydrochloride (Sigma, United
States) counterstained with Carazzi’s hematoxylin. Posi-
tive and negative controls were included in all reactions.
Expression of the proliferative markers was analyzed by
the ImageJ 1.43u program (Wayne Rasband, National
Institutes of Health, United States) using digital images
from 5 high-power ﬁelds (40) and calculating the
proliferative indices. Expression of all other antibodies
was considered negative (0-10% of positive cells) or
positive (>10% of positive cells), based on the average
percentage of positive cells in 10 high-power ﬁelds (40)
from each specimen analyzed under light microscopy,
regardless of staining intensity.
This study was carried out following the Helsinki
Declaration for study involving human subjects.RESULTS
Clinical and radiologic findings
Seventeen cases of CEOT were intraosseous and 2
extraosseous. The latter 2 cases had been previously
published as a case report affecting a single patient.9
Therefore, CEOT occurred in 18 patients, including 8
males (44.4%) and 10 females (55.6%), with a male-to-
female ratio of 1:1.3. Ages ranged from 13 to 65 years,
with a mean of 37.2  16.6 years (40.1  18.7 for
males and 35.1  15.6 for females). For central lesions,
12 cases affected the mandible (70.6%); 4, the maxilla
(23.5%); and the site was not speciﬁed in one case.
Topographical distribution showed that 5 cases
involved the anterior region (3 in the mandible and 2 in
the maxilla) and 11 involved the posterior region, 3 of
them including both premolar and molar areas. The
peripheral lesions occurred bilaterally on the gingival
tissue associated with the ﬁrst lower premolars.
Considering the information available for the intra-
osseous lesions, 14 patients presented swelling
(93.3%), and in one patient the lesion was an asymp-
tomatic incidental radiographic ﬁnding (6.7%). Twelve
patients (70.6%) reported no complaints associated with
the tumors, but 5 patients (29.4%) reported pain and
swelling in the affected area. Radiographically, 10 cases
(62.5%) presented as mixed radiopaque-radiolucent
lesions; 6 cases (37.5%) as radiolucencies, most of
them showing a unilocular pattern; and 10 cases
(71.4%) were associated with an unerupted tooth and
included upper and lower canines, lower ﬁrst premolar,
and upper and lower ﬁrst, second, and third molars
(Table I). No follow-up information was available.
The 4 DF-CEOT cases affected 1 male and 3 females,
with ages ranging from 8 to 19 years (mean, 15  4.8
years). Three cases affected lower third molars, and one
case affected an upper ﬁrst molar. The patients were
asymptomatic, but one of them showed a local swelling.
All cases presented as unilocular radiolucencies involving
Fig. 1. Histopathologic ﬁndings of calcifying epithelial odontogenic tumor. (A) Sheet of polyhedral epithelial cells characterizing
an epithelium-rich subtype (hematoxylin-eosin, original magniﬁcation 200). (B) Nuclear and cellular pleomorphism of the
epithelial cells (hematoxylin-eosin, original magniﬁcation 400). (C) Prominent intercellular bridges and cellular pleomorphism
(hematoxylin-eosin, original magniﬁcation 1000). (D) Homogeneous eosinophilic material interspersed by some cords of
epithelial cells characterizing an amyloid-rich subtype (hematoxylin-eosin, original magniﬁcation 400). (E) Extensive presence
of calciﬁed material in a calciﬁcation-rich subtype (hematoxylin-eosin, original magniﬁcation 100). (F) A balanced distribution of
epithelial, amyloid, and calciﬁed components in classic calcifying epithelial odontogenic tumor (hematoxylin-eosin, original
magniﬁcation 100).
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included classical and hyperplastic DF and dentigerous
cyst. Three cases were treated by tooth extraction, and one
case was managed by excision of the DF, allowing tooth
eruption. No follow-up information was available.Histopathologic findings
All cases of CEOT presented the typical microscopic
features of the tumor, including variable amounts of
sheets, islands, and cords of polyhedral epithelial cells
with large eosinophilic cytoplasm and well-deﬁned
boundaries, with prominent intercellular bridges and some
degree of nuclear pleomorphism. Amyloid and calciﬁca-
tion were also observed in variable amounts in 17 cases
(89.5%). Considering the distribution and proportion of
the aforementioned features, 8 cases were classiﬁed as
epithelium-rich (42.1%), 4 as amyloid-rich (21.1%), and 3
as calciﬁcation-rich (15.7%) (Figure 1). In the other 4
cases, there was a balanced distribution of these 3
components. Concentric layered calciﬁcations (Liesegang
rings) were observed in 7 cases (36.8%). Some epithelial
cells presented amyloid material in the cytoplasm. In
addition, 6 cases presented clear cells (31.6%), 3 had an
associated cystic epithelium (15.8%), and 1 had an
odontogenic ﬁbroma-like stroma (5.3%). The cribriformpattern described by Ai-Ru et al.3 was observed in 6 cases
(31.6%), duct-like areas were observed in 5 (26.3%), and
cells containing a brownish pigment, compatible with
melanin, were observed in 2 (10.5%) (Figure 2).
DF-CEOT showed both a loose and ﬁbrous con-
nective tissue with polygonal to ovoid odontogenic
epithelial cells, with an eosinophilic cytoplasm
(resembling CEOT epithelial cells), that represented
about 20% to 30% of the entire specimen. All 4 cases
also presented some calciﬁed material, one of these in
the form of Liesegang rings; 3 cases had an amyloid
material interspersed among the epithelial cells; 2 cases
showed remnants of reduced enamel epithelium; and 1
case also showed clear cells (Figure 3).Histochemical and immunohistochemical findings
Cases containing amyloid material were positive for
CR, showing a yellow-greenish birefringence on
polarized light; CR was also positive in the associated
calciﬁed tissue in 2 of these cases. PAS showed dia-
stase-digested positivity in the clear cells.
Immunohistochemical expression of the studied
proteins varied according to each CEOT component
evaluated. In general, epithelial tumor cells were posi-
tive for all epithelial markers and focally positive for
Fig. 2. Additional histopathologic features in calcifying epithelial odontogenic tumor. (A) Clear cells (hematoxylin-eosin, original
magniﬁcation 400). (B) Cystic epithelium (hematoxylin-eosin, original magniﬁcation 100). (C) Odontogenic ﬁbroma-like stroma
(hematoxylin-eosin, original magniﬁcation 400). (D) Cribriform pattern (hematoxylin-eosin, original magniﬁcation 200). (E)
Duct-like area (hematoxylin-eosin, original magniﬁcation 1000). (F) Brownish-pigmented cells (hematoxylin-eosin, original
magniﬁcation 400).
Fig. 3. Histopathologic ﬁndings of dental follicles containing calcifying epithelial odontogenic tumorelike areas. (A) Reduced
enamel epithelium outlining an area containing epithelial cells with a large eosinophilic cytoplasm and an eosinophilic extracellular
material (hematoxylin-eosin, original magniﬁcation 400). (B) Detail of epithelial cells and associated amyloid material (hema-
toxylin-eosin, original magniﬁcation 400). (C) Clear cells (hematoxylin-eosin, original magniﬁcation 400).
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CD138 in 1 case and for AA in 2 cases, and the asso-
ciated calciﬁed material was positive in peripheral areas
for CK5 in 1 case, for CD138 in 2 cases, and for AA in
7 cases (Table II; Figure 4). Clear cells had a similar
pattern of immunohistochemical expression to the other
epithelial tumor cells. Cystic epithelium was positive
for CK19, CD138, and E-cadherin and was also posi-
tive for AA in the most superﬁcial epithelial layers in 1
case. DF-CEOTs were positive for CK5, CK19,
CD138, and E-cadherin in all cases and focally positive
for AA in 1 case (see Table II; Figure 5). Ki-67 showeda higher labeling index in CEOT epithelial cells (3.04 
2.16%; range, 0.21%-7.58%) than in DF-CEOT ep-
ithelial cells (1.11  1.56%; range, 0% to 2.21%) and,
similarly, MCM-2 showed a higher labeling index in
CEOT epithelial cells (9.39  15.34%; range, 0%-
54.82%) than in DF-CEOT epithelial cells (5.27 
0.21%; range, 5.12%-5.41%).
SEM findings
The 3 CEOTs classiﬁed as calciﬁcation-rich were also
evaluated by SEM, and these calciﬁcations appeared as
areas similar to bone (Figure 6).
Table II. Immunohistochemical proﬁle of the tumoral components from the 19 cases of CEOT and the epithelial cells
in 4 cases of DF-CEOT*
Markers
CEOT (n/%)* DF-CEOT (n/%)*
Epithelial cells Amyloidy Calciﬁcationy Epithelial cellsz
Cytokeratin 5 15 (88.2%) 0 (0%) 1 (6.7%) 3 (100%)
Cytokeratin 19 16 (94.1%) 0 (0%) 0 (0%) 3 (100%)
Syndecan 1 (CD138) 17 (100%) 1 (6.7%) 2 (13.3%) 3 (100%)
E-cadherin 17 (100%) 0 (0%) 0 (0%) 3 (100%)
Amyloid A 13 (76.5%) 2 (13.3%) 7 (46.7%) 1 (33.3%)
CEOT, calcifying epithelial odontogenic tumor; DF-CEOT, dental follicles with calcifying epithelial odontogenic tumorelike areas.
*Immunohistochemical reactions were performed in 17 cases of CEOT and 3 cases of DF-CEOT.
yConsidering the 15 cases containing amyloid or calciﬁcation that were immunohistochemically studied.
zAmyloid was negative for all markers in all cases, and the periphery of calciﬁcation was positive for amyloid A in one case.
Fig. 4. Immunohistochemical ﬁndings of calcifying epithelial odontogenic tumor. (A) Cytokeratin 5 (CK5) expression in epithelial
cells (200). (B) CK19 expression in epithelial cells (200). (C) Syndecan 1 (CD138) expression in epithelial cells, amyloid, and
calciﬁcation (200). (D) E-cadherin expression in the epithelial junctions (400). (E) Amyloid A expression in the cytoplasm of
the epithelial cells and in the amyloid material (200). (F) Amyloid A expression at the periphery of the calciﬁed material (200).
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CEOT is considered an uncommon OT.1-3,10,11 To our
knowledge, the present study represents the second-
largest series on CEOT reported in the English-
language literature and the largest series from Latin
America. Furthermore, microscopic features similar to
those of CEOTs have been described in DFs, but it is
still debatable if these features represent solely
morphologic variations associated with the pluri-
potential nature of the odontogenic remnants, odonto-
genic hamartomas, or evidence of early CEOT.5-7
Intraosseous CEOTs are much more common than
their extraosseous counterparts and represent up to 95%
of the reported CEOTs (see Table I). The most common
radiologic presentation is a well-deﬁned radiolucent
image containing variable amounts of calciﬁed foci (seeTable I). The presence of an unerupted tooth associated
with CEOT may be observed in approximately one-
third of the cases, and when analyzed together with the
mean age of the patients, it reinforces the long-term
evolution of these tumors (see Table I). Mineralization
seems to be a continuous gradual phenomenon in
CEOT. When comparing age and radiologic images
from the present series of CEOT, the 9 cases presenting
radiolucent images showed a mean age of 24.2 years, in
contrast with a mean age of 44.6 years for the cases
presenting a mixed radiologic pattern. The 2 peripheral
cases from the present series involved the lower
premolar area from a single patient, a ﬁnding already
described in the literature in both peripheral and central
lesions.12,13 All but one of the 4 DF-CEOT cases
reported in the present study, similarly to the cases
Fig. 5. Immunohistochemical ﬁndings of dental follicles containing calcifying epithelial odontogenic tumorelike areas. (A)
Cytokeratin 5 (CK5) expression in epithelial cells including the reduced enamel epithelium (200). (B) CK19 expression in some
epithelial cells focally including the reduced enamel epithelium (200). (C) Syndecan 1 (CD138) expression in some epithelial cell
junctions focally including the reduced enamel epithelium (200). (D) E-cadherin expression in epithelial cell junctions including
the reduced enamel epithelium (200). (E) Amyloid A expression in few epithelial cells (200). (F) Detail of CD138 expression
in pleomorphic epithelial cells (400).
Fig. 6. Scanning electron microscopy ﬁndings of calcifying
epithelial odontogenic tumor. Calciﬁcations resembling bone
(500).
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tigated due to a thickened DF associated with a molar
tooth, and only one of them occurred in the maxilla,
ﬁndings that support the importance of performing
histologic examination in all pericoronal tissue.
Microscopic essential features for CEOT diagnosis
are characteristic and include 3 components that are
often easily recognized by most oral and maxillofacial
pathologists,3 although the histologic pattern and the
amount of these features could be quite variable. Due tothis microscopic variability, Ai-Ru et al.3 suggested
a classiﬁcation for CEOT considering 4 histomorpho-
logic patterns, found either isolated or combined, that
included different criteria for epithelial cytology and
histomorphology, stromal density and composition, and
calciﬁcation pattern. These microscopic patterns are not
commonly used in CEOT description.1,2 In the present
series, we have noticed that most of the cases showed 1
or 2 of the main CEOT components as the predominant
pattern, and that not all cases had conspicuous amyloid
or calciﬁcation. Absent or minimal calciﬁcation was
already described in a noncalcifying CEOT variant,
which is usually associated with Langerhans cells and
seems to have a predilection for anterior and premolar
areas,14 as it was seen in 1 of the 2 cases without
calciﬁcation from the present series. Considering the
cases we have classiﬁed according to the distribution
and proportion of epithelial, amyloid, and calciﬁed
components, we observed that the mean age of the
patients diagnosed with epithelium-rich, balanced
distribution, and amyloid/calciﬁcation-rich CEOT was
25.7 years, 38.7 years, and 48 years, respectively.
These mean age differences are probably reproducing
the microscopic transition from epithelial cells to
amyloid material and, gradually, to calciﬁcation. In the
present series, as expected, it was noticed that epithe-
lium-rich CEOTs were mainly diagnosed as radiolucent
images (75%), whereas amyloid/calciﬁed-rich CEOTs
OOOO ORIGINAL ARTICLE
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images (80%).
Clear cells were found in about one-third of the cases
in the present CEOT series, including the 2 peripheral
cases. It has been suggested that the presence of this
component causes a more aggressive behavior in
CEOTs, but there is little evidence to support this
statement.15 It is worthwhile to mention that clear cells
may represent a diagnostic challenge when analyzing
small incisional biopsies, as salivary gland tumors,
metastatic malignancies, or other OTs can also contain
clear cells and should be included in the differential
diagnosis.3,10 In the present series, clear cells were
found in 4 of the 17 central CEOTs (23%) and in the 2
peripheral CEOTs (100%), suggesting that this
component is more common in the latter.13 Interest-
ingly, clear cells were not found in these 2 extraosseous
CEOTs when they were ﬁrstly studied for the previous
submission,9 and clear cells were encountered only
when additional sections were obtained for the present
study.
The cystic epithelium observed in 3 of the pres-
ent cases had been previously described as the
main histologic component in intraosseous CEOTs.16
According to these authors, this phenomenon may
result from cystic degeneration from a solid tumor, or
the tumor may itself present a cystic pattern of
growth.16 The presence of an odontogenic ﬁbroma-like
stroma had not been previously reported in CEOT,
although Dunlap17 had described the presence of
eosinophilic, amorphous globules weakly stained for
amyloid, and Eversole18 had recently described
a similar case that he named as amyloid-producing
variant of odontogenic ﬁbroma. In the present case,
apart from the odontogenic ﬁbroma-like areas, there
were typical epithelial CEOT areas all over the spec-
imen, which were essential for ﬁnal diagnosis. It is
noteworthy that, in some cases, it may be difﬁcult to
differentiate CEOT from odontogenic ﬁbroma, espe-
cially in the variant formerly named as the World
Health Organization type.19 In addition, the brownish-
pigmented cells observed in 2 of our cases had already
been described as a rare ﬁnding in benign and malig-
nant OT, not including CEOT.20 The clinical implica-
tion of all these histologic features in CEOT is still
unknown.
It has been postulated that CEOT originates from
remnant cells from the stratum intermedium of the
enamel organ, dental lamina, or basal cells of the
surface epithelium.1,3 Moreover, DF epithelium has
been suggested as the source of some odontogenic
cysts, central OTs, and odontogenic hamartomatous
proliferations.6 It may be also proliferative and ex-
hibit squamous metaplasia and mucous cell proso-
plasia.4 These observations highlight the pluripotentialcapability of differentiation of DF and justify the
possible presence of CEOT-like areas within a DF.
Additionally, it is also not uncommon that follicular
soft tissues associated with asymptomatic third molars
may reveal early odontogenic cysts and tumors,
including CEOT.5,21 It is possible that if these early
odontogenic lesions were not removed and were fol-
lowed up for some years, they would develop into a true
odontogenic cyst or tumor, such as the case of a previ-
ously reported pericoronal CEOT followed up for 6
years.22
DF-CEOT included in the present series showed
clinicoradiologic features of classical DF associated
with the histologic presence of a prominent prolifera-
tion of odontogenic epithelium arranged in nests and
cords interspersed by calciﬁed material, including Lie-
segang rings and an extracellular eosinophilic substance
resembling CEOT. The presence of reduced enamel
epithelium in close association with CEOT-like areas
was also described in the 2 cases of DF-CEOT reported
by Ide et al.,6 but the presence of associated clear cells
within CEOT-like areas had not been previously re-
ported. Hyperplastic clear cell rests had been previously
identiﬁed in association with DF,6 and 2 early CEOT
were reported outside the periodontal ligament space in
jaw biopsies revised by Bouquot et al.23 Thus, the
existence of DF-CEOT and incipient CEOT without
clinical signs and symptoms, allied to the common
presence of unerupted teeth in association with CEOT,
lead one to consider dental lamina remnants, especially
the reduced enamel epithelium, as a source of CEOT, as
well as to postulate that DF-CEOT may progress
toward a genuine CEOT.
In the present series, epithelial cells showed posi-
tivity for CK5, CK19, CD138, and E-cadherin in all
cases of DF-CEOT and in almost all cases of CEOT.
CK5 and CK19 are present in the human tooth organ,
and they have been regularly described in the epithe-
lium of other OTs.24,25 CK19 and a cocktail containing
CK5 and CK6 were already identiﬁed in CEOT,24,26,27
and it was suggested that CK5/CK6 expression prob-
ably represented myoepithelial differentiation, although
it is not speciﬁc and may be also identiﬁed in normal
and neoplastic epithelium.27 CD138 and E-cadherin are
molecules associated with epithelial intercellular adhe-
sion, and their reduced or absent expression is usually
associated with invasiveness of tumors.28,29 Expression
of CD138 and E-cadherin seems to play a role during
odontogenesis and in some OT development.28-31
Bologna-Molina et al.29,32 showed that there is a lower
CD138 expression in solid ameloblastoma than in
unicystic ameloblastoma and that there is also a lower
CD138 expression in ameloblastic carcinoma when
compared to solid ameloblastoma, ﬁndings that support
the association of decreased CD138 expression with
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described as a locally invasive tumor,1-3,10,11 CD138
expression found in the present study supports that
adhesion characteristics of the tumor cells in CEOT
seem to be maintained. The E-cadherin molecule was
previously identiﬁed in 2 cases of CEOT, and its
expression did not include cell surfaces adjacent to the
amyloid and calciﬁcation.28 The present results also
showed that E-cadherin expression in CEOT was
restricted to the epithelial component. This expression
in some OTs seems to be more associated with histo-
genesis and cytodifferentiation than prognosis, since it
was similarly observed in tooth germs, CEOT, solid and
unicystic ameloblastoma, ameloblastic carcinoma and
clear cell OT.28,31 CK5 and CD138 showed focal
expression in the edge of the calciﬁed material, and
CD138 was also expressed in the amyloid, probably
representing epithelial remnants maintained after tran-
sition from epithelial cells to amyloid and calciﬁcation
that may be observed in CEOT. It is noteworthy that
clear cells in both CEOT and DF-CEOT were equally
positive for CK5, CK19, E-cadherin, and CD138, and
that CK19, CD138, and E-cadherin expressions were
not observed in all cells within a single tumor in up to
17.7% of the CEOT cases.
AA is a pathologic intracellular or extracellular
ﬁbrillar protein derived from the cleavage of a larger
precursor named serum amyloid-associated protein, and
there is also an odontogenic ameloblast-associated
protein (ODAM), which originates a type of localized
amyloid associated with some OTs,33 including
CEOT.7,34,35 In the present CEOT series, amyloid
showed positivity for AA in only 2 cases, but epithelial
cells were focally positive in most of the cases, and
calciﬁcation (including Liesegang rings) showed
a peripheral positivity in almost half of the cases.
Considering ODAM immunohistochemical reactions in
CEOT, it is interesting to notice that, unlike AA
expression, it was mainly identiﬁed in the amyloid
material, although it also could be observed in some
epithelial cells and in the edge of mineralized structures
excluding Liesegang rings.7,34,35 Therefore, considering
the microscopic transition observed among epithelial,
amyloid, and calciﬁed elements in CEOT and the
amyloid immunohistochemical proﬁle described, we
could speculate that AA identiﬁed in the cytoplasm of
epithelial cells undergoes extracellular changes in its
composition, becoming immunonegative in the amyloid
material, which, in turn, is usually immunopositive for
ODAM.7,35 Expression of AA and ODAM in the
periphery of calciﬁed material is probably justiﬁed
by the presence of epithelial and amyloid remnants.
DF-CEOT also presented a case containing some AA-
positive epithelial cells, reinforcing its role as a poten-
tial source of CEOT.Ki-67 and MCM-2 are proteins identiﬁed during the
cell cycle that are commonly used as immunohisto-
chemical proliferative markers.36 In CEOT, only Ki-67
expression was already described, especially in cases
assessing the possibility of a malignant behavior.37 In
our study, the use of these proliferative markers showed
that MCM-2 presented a higher labeling index than
Ki-67 in both CEOT and DF-CEOT, ﬁndings previ-
ously described in other oral lesions, including DF.4,36
This is acceptable, as MCM-2 can be observed in all
phases of the cell cycle, whereas Ki-67 is not observed
in the early G1 phase.36 The lower labeling index
observed in DF-CEOT in comparison with CEOT was
expected due to the nature of these lesions, even if we
speculate that the former represent a precursor of the
latter. It is remarkable that the mean MCM-2 labeling
index (5.3%) observed in these DF-CEOT cases is
similar to the mean values observed in a series of DF
without CEOT areas (5.9%),4 although the mean Ki-67
labeling index was quite higher in their cases (10.5%),
particularly in DF containing mucous prosoplasia,
squamous metaplasia, or inﬂammation.4
SEM study was performed to highlight the pattern of
calciﬁcation in CEOT and revealed that this material
was similar to bone in most of the areas. Calciﬁcation is
described in CEOT as being primarily dystrophic, but
there are reports considering the presence of cementum-
like material.38 More studies on CEOT histogenesis
focusing on the calciﬁed component will help to
elucidate this subject.
In conclusion, CEOT is usually diagnosed as a radio-
lucent image when affecting youngsters, whereas in
older patients it is characterized by a mixed radiopaque-
radiolucent image. Pathologic proﬁle and variants are
characterized by quantity and distribution of 3 constant
elementsdepithelium, amyloid, and calciﬁcation. Age at
diagnosis also varies according to microscopic appear-
ance, usually being younger in epithelium-rich cases
and older in amyloid- or calciﬁcation-rich cases. DF-
CEOT showed histomorphologic and immunohisto-
chemical similarities to pericoronal CEOT in this study,
but whether areas of CEOT in DF represent a CEOT
precursor or an early phenomenon in CEOT devel-
opment in cases associated with an unerupted tooth
should be further studied and discussed in larger series of
cases.
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